{Reference Type}: Journal Article
{Title}: Evolution and host-specific adaptation of Pseudomonas aeruginosa.
{Author}: Weimann A;Dinan AM;Ruis C;Bernut A;Pont S;Brown K;Ryan J;Santos L;Ellison L;Ukor E;Pandurangan AP;Krokowski S;Blundell TL;Welch M;Blane B;Judge K;Bousfield R;Brown N;Bryant JM;Kukavica-Ibrulj I;Rampioni G;Leoni L;Harrison PT;Peacock SJ;Thomson NR;Gauthier J;Fothergill JL;Levesque RC;Parkhill J;Floto RA;
{Journal}: Science
{Volume}: 385
{Issue}: 6704
{Year}: 2024 Jul 5
{Factor}: 63.714
{DOI}: 10.1126/science.adi0908
{Abstract}: The major human bacterial pathogen Pseudomonas aeruginosa causes multidrug-resistant infections in people with underlying immunodeficiencies or structural lung diseases such as cystic fibrosis (CF). We show that a few environmental isolates, driven by horizontal gene acquisition, have become dominant epidemic clones that have sequentially emerged and spread through global transmission networks over the past 200 years. These clones demonstrate varying intrinsic propensities for infecting CF or non-CF individuals (linked to specific transcriptional changes enabling survival within macrophages); have undergone multiple rounds of convergent, host-specific adaptation; and have eventually lost their ability to transmit between different patient groups. Our findings thus explain the pathogenic evolution of P. aeruginosa and highlight the importance of global surveillance and cross-infection prevention in averting the emergence of future epidemic clones.